Anti-LRRK2 (phospho T1357) antibody [MJF-R29-52]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal LRRK2 phospho T1357 antibody. Suitable for WB and reacts with Human samples. Cited in 3 publications.
View Alternative Names
PARK8, LRRK2, Leucine-rich repeat serine/threonine-protein kinase 2, Dardarin
- WB
Lab
Western blot - Anti-LRRK2 (phospho T1357) antibody [MJF-R29-52] (AB270606)
Blocking and diluting buffer and concentration : 5% NFDM/TBST. The G2019S leucine-rich repeat kinase 2 (LRRK2) mutation is the most common cause of genetic Parkinson's disease (PD). Transfection of G2019S mutant can lead to the phosphorylation of LRRK2 at Thr1357. The immunoprecipitates were kindly provided by Dr. Dario Alessi. Exposure time : 3 minutes.
All lanes:
Western blot - Anti-LRRK2 (phospho T1357) antibody [MJF-R29-52] (ab270606) at 1/1000 dilution
Lane 1:
Immunoprecipitates of overexpressed FLAG-LRRK2 G2019S in HEK293 cells, subjected to an in vitro kinase reaction prior to SDS-PAGE analysis at 10 µL
Lane 2:
Immunoprecipitates of overexpressed FLAG-LRRK2 D2017A in HEK293 cells, subjected to an in vitro kinase reaction prior to SDS-PAGE analysis at 10 µL
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 286 kDa
Observed band size: 288 kDa
false
Related conjugates and formulations (1)
-
Anti-LRRK2 (phospho T1357) antibody [MJF-R29-52] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Collaborations
This antibody was developed with support from The Michael J. Fox Foundation.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LRRK2 interacts with cellular mechanisms by regulating cytoskeletal dynamics autophagy and vesicle trafficking. It is a part of a larger complex that includes other proteins involved in these processes. The kinase activity of LRRK2 plays an essential part in maintaining neuronal health and function. It influences the process of autophagy which is a way cells clean themselves by removing damaged components and recycling them.
Pathways
The action of LRRK2 is central to the mitogen-activated protein kinase (MAPK) and the mammalian target of rapamycin (mTOR) pathways. In these pathways LRRK2 interacts with other proteins such as mTOR and RPS6KB1. It modulates cellular processes like growth proliferation and response to stressors. Its kinase activity affects the phosphorylation state of targets within the pathways hence influencing biological outcomes like survival and apoptosis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Annals of the rheumatic diseases 83:926-944 PubMed38325908
2024
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 120:e2309698120 PubMed37844218
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Biochemical journal 479:1759-1783 PubMed35950872
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com